Abstract
A recent analysis of R&D productivity suggests that there are grounds for 'cautious optimism' that the industry 'turned the corner' in 2008 and is 'on the comeback trail'.We believe that this analysis is flawed and most probably wrong.We present an alternative analysis of these same data to suggest that the industry is not yet 'out of the woods' and suggest that many of the systemic issues affecting pharmaceutical R&D productivity are still being resolved.
Author supplied keywords
Cite
CITATION STYLE
APA
Lendrem, D., Senn, S. J., Lendrem, B. C., & Isaacs, J. D. (2015). R&D productivity rides again? Pharmaceutical Statistics, 14(1), 1–3. https://doi.org/10.1002/pst.1653
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free